Value-Based Contracting: Key Considerations for Life Sciences Manufacturers
David Gilman, Ilina Sen, Kirsten Kester
Huron examines the trends and market events driving the emergence of value-based contracting (VBC), and how life sciences companies can prepare for a value-based future across commercial, R&D, IT, compliance and GP functions.
The article addresses:
- What the VBC model means and entails
- The relevance of the VBC model today
- Key considerations for manufacturers when implementing a VBC model